Aspire Capital Fund LLC 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-02 06:21 am Purchase |
2020-07-01 | 13G | Akari Therapeutics, Plc AKTX |
Aspire Capital Fund LLC | 33,679,045 19.890% |
33,679,045 (New Position) |
Filing |